Literature DB >> 19893009

Papillary thyroid cancer incidence in the volcanic area of Sicily.

Gabriella Pellegriti1, Florent De Vathaire, Claudia Scollo, Marco Attard, Carla Giordano, Salvatore Arena, Gabriella Dardanoni, Francesco Frasca, Pasqualino Malandrino, Francesco Vermiglio, Domenico Massimo Previtera, Girolamo D'Azzò, Francesco Trimarchi, Riccardo Vigneri.   

Abstract

BACKGROUND: The steadily increasing incidence of thyroid cancer has been attributed mostly to more sensitive thyroid nodule screening. However, various environmental factors, such as those associated with volcanic areas, cannot be excluded as risk factors. We evaluated thyroid cancer incidence in Sicily, which has a homogenous population and a province (Catania) that includes the Mt Etna volcanic area.
METHODS: In a register-based epidemiological survey, we collected all incident thyroid cancers in Sicily from January 1, 2002, through December 31, 2004. The age-standardized incidence rate for the world population (ASR(w)) was calculated and expressed as the number of thyroid cancer diagnoses per 100 000 residents per year. The association of thyroid cancer incidence rate with sex, age, tumor histotype, and various environmental factors was evaluated by modeling the variation of the ASR(w). All statistical tests were two-sided.
RESULTS: In 2002-2004, 1950 incident thyroid cancers were identified in Sicily (among women, ASR(w) = 17.8, 95% confidence interval [CI] = 16.9 to 18.7; and among men, ASR(w) = 3.7, 95% CI = 3.3 to 4.1). Although the percentage of thyroid cancers that were microcarcinomas (ie, < or = 10 mm) and ratio of men to women with thyroid cancer were similar in all nine Sicilian provinces, thyroid cancer incidence was statistically significantly higher in the province of Catania (among women, ASR(w) = 31.7, 95% CI = 29.1 to 34.3; and among men, ASR(w) = 6.4, 95% CI = 5.2 to 7.5) than in the rest of Sicily (among women, ASR(w) = 14.1, 95% CI = 13.2 to 15.0; and among men, ASR(w) = 3.0, 95% CI = 2.6 to 3.4) (all P values < .001). Incidence of papillary, but not follicular or medullary, cancers was statistically significantly increased in Catania province, and papillary tumors from patients in Catania more frequently carried the BRAF V600E gene mutation (55 [52%] of 106 tumors) than tumors from patients elsewhere in Sicily (68 [33%] of 205 tumors) (relative risk = 1.7, 95% CI = 1.0 to 2.8, P = .02). Cancer incidence was statistically significantly lower in rural areas than in urban areas of Sicily (P = .003). No association with mild iodine deficiency or industrial installations was found. Levels of many elements (including boron, iron, manganese, and vanadium) in the drinking water of Catania province often exceeded maximum admissible concentrations, in contrast to water in the rest of Sicily.
CONCLUSION: Residents of Catania province with its volcanic region appear to have a higher incidence of papillary thyroid cancer than elsewhere in Sicily.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893009     DOI: 10.1093/jnci/djp354

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

1.  Prevalence of Cancer in Patients with Thyroid Nodules in the Island of Cyprus: Predictive Value of Ultrasound Features and Thyroid Autoimmune Status.

Authors:  Irini S Hadjisavva; Roberto Dina; Michael A Talias; Panayiotis A Economides
Journal:  Eur Thyroid J       Date:  2015-05-30

2.  Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara.

Authors:  L Pagano; M Caputo; M T Samà; V Garbaccio; M Zavattaro; M G Mauri; F Prodam; P Marzullo; R Boldorini; G Valente; G Aimaretti
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

3.  Improving the prediction of malignancy in cytologically suspicious thyroid nodules.

Authors:  S Arena; A Latina; I Marturano; V Muscia; G L La Rosa; M Stornello; S Squatrito; S Italia; R Vigneri
Journal:  J Endocrinol Invest       Date:  2013-05-06       Impact factor: 4.256

4.  DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.

Authors:  Christine E Lehman; Laura W Dillon; Yuri E Nikiforov; Yuh-Hwa Wang
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

5.  Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?

Authors:  Rossella Elisei
Journal:  J Clin Endocrinol Metab       Date:  2014-02       Impact factor: 5.958

6.  How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?

Authors:  Loredana Pagano; Chiara Mele; Debora Arpaia; Maria Teresa Samà; Marina Caputo; Serena Ippolito; Carmela Peirce; Flavia Prodam; Guido Valente; Giuseppe Ciancia; Gianluca Aimaretti; Bernadette Biondi
Journal:  Endocrine       Date:  2016-05-26       Impact factor: 3.633

7.  Volcanic environments: "biomonitoring" their links to thyroid cancer.

Authors:  Leonidas H Duntas
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

8.  Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Authors:  Pasqualino Malandrino; Marco Russo; Anna Ronchi; Claudio Minoia; Daniela Cataldo; Concetto Regalbuto; Carla Giordano; Marco Attard; Sebastiano Squatrito; Francesco Trimarchi; Riccardo Vigneri
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

9.  Increasing incidence of thyroid cancer: controversies explored.

Authors:  Yasuhiro Ito; Yuri E Nikiforov; Martin Schlumberger; Riccardo Vigneri
Journal:  Nat Rev Endocrinol       Date:  2013-01-29       Impact factor: 43.330

10.  Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania.

Authors:  Darrin V Bann; Neerav Goyal; Fabian Camacho; David Goldenberg
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.